Liver fat change in obese children after a 1-year nutrition-behavior intervention

Carlo Pozzato1, Elvira Verduci, Silvia Scaglioni

  • 1Department of Radiology, San Paolo Hospital, University of Milan, Milan, Italy.

Insights

A 1-year nutrition and exercise program significantly reduced liver fat in obese children. This intervention improved metabolic markers and decreased the prevalence of childhood non-alcoholic fatty liver disease.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Metabolic Disorders

Background:

  • Childhood obesity is a growing concern linked to non-alcoholic fatty liver disease (NAFLD).
  • NAFLD in children can lead to serious long-term health complications.
  • Effective interventions are crucial for managing pediatric obesity and its associated liver conditions.

Purpose of the Study:

  • To investigate the efficacy of a 1-year nutrition-behavior intervention in reducing liver fat in obese children.
  • To assess the impact of a balanced diet and physical activity on liver steatosis and related metabolic parameters.

Main Methods:

  • A 1-year intervention study involving 26 obese children (ages 6-14).
  • Intervention included a normocaloric balanced diet and physical exercise.
  • Evaluations included anthropometry, metabolic markers, and liver magnetic resonance imaging (MRI) to determine hepatic fat fraction (FF).

Main Results:

  • Liver steatosis prevalence decreased from 34.6% to 7.7% (P < 0.0001).
  • Mean liver fat fraction (FF) reduced by 8.0% (P < 0.0001), with 77.8% of affected children showing normalization.
  • Significant improvements observed in body mass index z-score, waist circumference, and lipid profiles.

Conclusions:

  • Nutritional-behavior interventions are effective in reducing liver fat in obese children.
  • This approach offers a promising strategy for managing non-alcoholic fatty liver disease in pediatric populations.
  • Lifestyle modifications can positively impact metabolic health and liver steatosis in children.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...